ロード中...
Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines
Effective molecular target drugs that improve therapeutic efficacy with fewer adverse effects for esophageal cancer are highly anticipated. Poly(ADP-ribose) polymerase (PARP) inhibitors have been proposed as low-toxicity agents to treat double strand break (DSB)-repair defective tumors. Several find...
保存先:
| 出版年: | Cancer Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317825/ https://ncbi.nlm.nih.gov/pubmed/24219164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12322 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|